Expression and function of T cell homing molecules in Hodgkin's lymphoma

Cancer Immunology, Immunotherapy

Volumn 58, Issue 1, 2009, Pages 85-94

  Machado, Lee ^a   Jarrett, Ruth ^b   Morgan, Susan ^a   Murray, Paul ^a   Hunter, Beatrix ^a   Hamilton, Emma ^a   Crocker, John ^c   Thomas, Wendy ^a   Steven, Neil ^a   Ismail, Tariq ^d   Chapman, Ann ^a,e   Adams, David H ^a   Lee, Steven P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^e ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Chemokines; Hodgkin's lymphoma; T cell homing; Tumour Immunity

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HOMING RECEPTOR; L SELECTIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL ADHESION; CELL ISOLATION; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; T LYMPHOCYTE; TISSUE DIFFERENTIATION; TUMOR IMMUNITY; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FLOW CYTOMETRY; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTORS, CXCR; RECEPTORS, LYMPHOCYTE HOMING; YOUNG ADULT;

EID: 54849416983     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-008-0528-z     Document Type: Article

References (29)

1. CM Bollard L Aguilar KC Straathof B Gahn MH Huls A Rousseau J Sixbey MV Gresik G Carrum M Hudson D Dilloo A Gee MK Brenner CM Rooney HE Heslop 2004 Cytotoxic T lymphocyte therapy for Epstein-Barr virus + Hodgkin's disease J Exp Med 200 1623
2. H Chambost N Van Baren F Brasseur D Godelaine L Xerri SJ Landi I Theate J Plumas GC Spagnoli G Michel PG Coulie D Olive 2000 Expression of gene MAGE-A4 in Reed-Sternberg cells Blood 95 3530
3. ME Dudley JR Wunderlich PF Robbins JC Yang P Hwu DJ Schwartzentruber SL Topalian R Sherry NP Restifo AM Hubicki MR Robinson M Raffeld P Duray CA Seipp L Rogers-Freezer KE Morton SA Mavroukakis DE White SA Rosenberg 2002 Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 850
4. SL Glaser RJ Lin SL Stewart RF Ambinder RF Jarrett P Brousset G Pallesen ML Gulley G Khan J OGrady M Hummel MV Preciado H Knecht JC Chan A Claviez 1997 Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data Int J Cancer 70 375
5. G Guarda M Hons SF Soriano AY Huang R Polley A Martin-Fontecha JV Stein RN Germain A Lanzavecchia F Sallusto 2007 L-selectin-negative CCR7-effector and memory CD8 + T cells enter reactive lymph nodes and kill dendritic cells Nat Immunol 8 743
6. T Haque C Taylor GM Wilkie P Murad PL Amlot S Beath PJ McKiernan DH Crawford 2001 Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells Transplantation 72 1399
7. NL Harris ES Jaffe H Stein PM Banks JK Chan ML Cleary G Delsol C Wolf-Peeters B Falini KC Gatter 1994 A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 84 1361
8. UE Hopken HD Foss D Meyer M Hinz K Leder H Stein M Lipp 2002 Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs Blood 99 1109
9. T Ishida T Ishii A Inagaki H Yano H Komatsu S Iida H Inagaki R Ueda 2006 Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege Cancer Res 66 5716
10. R Khanna S Bell M Sherritt A Galbraith SR Burrows L Rafter B Clarke R Slaughter MC Falk J Douglass T Williams SL Elliott DJ Moss 1999 Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease Proc Natl Acad Sci USA 96 10391
11. EM Maggio BA Van Den L Visser A Diepstra J Kluiver R Emmens S Poppema 2002 Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical Hodgkin lymphomas Int J Cancer 99 665
12. J Middleton S Neil J Wintle I Clark-Lewis H Moore C Lam M Auer E Hub A Rot 1997 Transcytosis and surface presentation of IL-8 by venular endothelial cells Cell 91 385
13. Niens M, Visser L, Nolte IM, van der SG, Diepstra A, Cordano P, Jarrett RF, Te Meerman GJ, Poppema S, Van Den BA (2008) Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22. Br J Haematol 140: 527
14. K Ohshima T Tutiya T Yamaguchi K Suzuki J Suzumiya C Kawasaki S Haraoka M Kikuchi 2002 Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: relation with expression of CXC and CC chemokines on H&RS cells Int J Cancer 98 567
15. DJ Powell Jr ME Dudley PF Robbins SA Rosenberg 2005 Transition of late-stage effector T cells to CD27 + CD28 + tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy Blood 105 241
16. CM Rooney CA Smith CC Ng S Loftin CF Li RA Krance MK Brenner HE Heslop 1995 Use of gene modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation Lancet 345 9
17. CM Rooney CA Smith CC Ng SK Loftin JW Sixbey YJ Gan DK Srivastava LC Bowman RA Krance MK Brenner HE Heslop 1998 Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients Blood 92 1549
18. A Rot UH von Andrian 2004 Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells Annu Rev Immunol 22 891
19. F Sallusto E Kremmer B Palermo A Hoy P Ponath S Qin R Forster M Lipp A Lanzavecchia 1999 Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells Eur J Immunol 29 2037
20. M Salmi S Tohka EL Berg EC Butcher S Jalkanen 1997 Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes J Exp Med 186 589
21. ML Scimone TW Felbinger IB Mazo JV Stein UH von Andrian W Weninger 2004 CXCL12 mediates CCR7-independent homing of central memory cells, but not naive T cells, in peripheral lymph nodes J Exp Med 199 1113
22. BF Skinnider TW Mak 2002 The role of cytokines in classical Hodgkin lymphoma Blood 99 4283
23. CM Stolen F Marttila-Ichihara K Koskinen GG Yegutkin R Turja P Bono M Skurnik A Hanninen S Jalkanen M Salmi 2005 Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo Immunity 22 105
24. J TeruyaFeldstein ES Jaffe PR Burd DW Kingma JE Setsuda G Tosato 1999 Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia Blood 93 2463
25. B Thurner I Haendle C Roder D Dieckmann P Keikavoussi H Jonuleit A Bender C Maczek D Schreiner P von den Driesch EB Brocker RM Steinman A Enk E Kampgen G Schuler 1999 Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma J Exp Med 190 1669
26. A van den Berg L Visser S Poppema 1999 High expression of the CC Chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma Am J Pathol 154 1685
27. UH von Andrian TR Mempel 2003 Homing and cellular traffic in lymph nodes Nat Rev Immunol 3 867
28. MR Weihrauch O Manzke M Beyer H Haverkamp V Diehl H Bohlen J Wolf JL Schultze 2005 Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor Cancer Res 65 5516
29. C Yee JA Thompson D Byrd SR Riddell P Roche E Celis PD Greenberg 2002 Adoptive T cell therapy using antigen-specific CD8 + T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells Proc Natl Acad Sci USA 99 16168